Now surgeons can see blood flow while working on blood vessels—safely, seamlessly.
… with Viewflow smart camera.
It’s redefining how millions of operations a year are done, with top surgeons ready to deploy.

Surgeons can’t reliably see live blood flow during surgery because their options are limited.
Giving surgeons real-time “vision” into blood vessel flow may help reduce their time, patient complications, and costs.
For you, it’s a chance to back something meaningful with real clinical and financial upsides.

Massive Problem
1 in 5 bypass grafts end up with poor flow. 1 in 7 reconstruction flaps fail completely – tissue dies.
The #1 problem surgeons face is knowing if the procedure ends with adequate blood flow.
Dr. Vip Patel, 19,000 robotics surgeries

Easy Breakthrough
Point the camera. See AI-enhanced, real-time vessel flow – a world first: no dyes, no probes, or no x-rays.
After seeing this level of information, it would be difficult to operate without it
Chief Heart Surgeon, Dr. Theodoro

Performance of Novadaq (dye)
Same surgeons, same workflow, no dye
Grow at 50%. Exit 3-4 yrs at 10–22x salesChart excludes 2008–2010 U.S. financial crisis (Years 2–3)

FDA Surgical Camera.
Multiple hospitals ready for clinical programs (including major Houston and UNC networks).
ViewFlow can share in savings to payers and hospitals where it saves costly complications or insulates against legal liability.
Pros who’ve built and sold health‑tech products.

Jim Sund, PhD, CEO
NASA Fellow | Commercialized health-tech to Roche & Merck
Proven Path to Market & Exit

Randall Wolf, MD
Houston Methodist, DeBakey Heart & Vascular Center
Data‑driven wins

Kimberly Steinmann, MD
Clinical Studies Lead Advisor
Useful for many procedures

Dennis Robbins, PhD, MPH
Chief Strategy & Payment Advisor and National Thought Leader

Investing in ViewFlow was easy and exciting.
I love knowing my money helps real people recover faster.
Viewflow may well change the standard of care.
Safer, smarter, and seamless.
$4.5M sold of $5M
to ship to surgeons
